# A Post-Market Clinical Evaluation of the ReUnion Reversible Fracture (RFX) System

> **NCT04089371** · — · TERMINATED · sponsor: **Stryker Trauma and Extremities** · enrollment: 10 (actual)

## Conditions studied

- Arthroplasty
- Hemiarthroplasty
- Shoulder Pain

## Interventions

- **DEVICE:** ReUnion Total Shoulder Arthroplasty (TSA)
- **DEVICE:** ReUnion Reverse Shoulder Arthroplasty (RSA)

## Key facts

- **NCT ID:** NCT04089371
- **Lead sponsor:** Stryker Trauma and Extremities
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-01
- **Primary completion:** 2022-07-08
- **Final completion:** 2022-07-08
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Sponsor Terminated
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04089371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04089371, "A Post-Market Clinical Evaluation of the ReUnion Reversible Fracture (RFX) System". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04089371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*